Assam reported 270 fresh COVID-19 cases and seven fatalities in the last 24 hours, informed the state health department on Tuesday.
The death toll has climbed to 4,59,191 with 311 daily fatalities, the data updated at 8 am showed.
The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine.
The vaccine is one-third the adult dose and the it would be given in two doses, three weeks apart. The lower dose was chosen to minimize side effects and still produce strong immunity, said Pfizer.
The commerce ministry directive late on Monday stirred some concern on domestic social media that it may have been triggered by heightened tensions with Taiwan
Chhattisgarh's Covid-19 count reached 10,06,096 on Tuesday
Maharashtra on Tuesday reported 1,078 fresh Covid-19 cases, a rise of 269 from a day ago
As many as 64,999 samples were tested in the last 24 hours
The last Covid death that Bengaluru had recorded was on August 23
The observation by Justice P V Kunhikrishnan came during the hearing of a man's plea for a third jab of an internationally recognised vaccine so that he can go abroad for work
This included 73 people who had a positive SARS-CoV-2 polymerase chain reaction (PCR) test result before the first vaccine dose.
The daily rise in new coronavirus infections has been below 20,000 for 25 straight days and less than 50,000 daily new cases have been reported for 128 consecutive days now.
The backing of Australia could tip the scale in favour of Covaxin when the WHO meets on November 3
The vaccine will be manufactured by SII in India and marketed by it in Indonesia under the brand name Covovax, Novavax Inc said in a statement
The city has logged less than 300 COVID-19 cases after a gap of four days
With 7,325 more people recovering from the virus since Sunday, the total recoveries touched 48,64,506 and the active cases reached 76,786
Indonesia first to green light Novavax COVID-19 vaccine
Describing it as an extraordinary feat, he said India is rapidly progressing on the path to defeating the virus
Hyderabad-based Bharat Biotech's Covaxin, and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India
India has so far administered 1,063,124,205 vaccine doses. That is 3100.76 per cent of its total caseload, and 76.09 per cent of its population